Sequent Scientific Valuation
| SEQUENT Stock | 199.27 1.09 0.55% |
At this time, the company appears to be fairly valued. Sequent Scientific has a current Real Value of USD199.05 per share. The regular price of the company is USD199.27. Our model measures the value of Sequent Scientific from inspecting the company fundamentals such as Shares Outstanding of 249.35 M, operating margin of 0.07 %, and Return On Equity of -0.0405 as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 7.2873 | Enterprise Value 53.7 B | Enterprise Value Ebitda 37.4552 | Price Sales 3.4923 | Forward PE 33.3333 |
Fairly Valued
Today
Please note that Sequent Scientific's price fluctuation is very steady at this time. Calculation of the real value of Sequent Scientific is based on 3 months time horizon. Increasing Sequent Scientific's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Sequent Scientific's intrinsic value may or may not be the same as its current market price of 199.27, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 199.27 | Real 199.05 | Hype 199.54 | Naive 177.62 |
The intrinsic value of Sequent Scientific's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sequent Scientific's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sequent Scientific Limited helps investors to forecast how Sequent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sequent Scientific more accurately as focusing exclusively on Sequent Scientific's fundamentals will not take into account other important factors: Sequent Scientific Cash |
|
Sequent Scientific Total Value Analysis
Sequent Scientific Limited is at this time forecasted to have takeover price of 53.69 B with market capitalization of 48.54 B, debt of 4.88 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sequent Scientific fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
53.69 B | 48.54 B | 4.88 B |
Sequent Scientific Investor Information
About 53.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 8th of September 2021. Sequent Scientific had 10:2 split on the 25th of February 2016. Based on the measurements of operating efficiency obtained from Sequent Scientific's historical financial statements, Sequent Scientific Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Sequent Scientific Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Sequent implies not a very effective usage of assets in November.Sequent Scientific Ownership Allocation
Sequent Scientific shows a total of 249.35 Million outstanding shares. Sequent Scientific maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sequent Scientific Profitability Analysis
The company reported the revenue of 13.7 B. Net Loss for the year was (358.69 M) with profit before overhead, payroll, taxes, and interest of 5.63 B.About Sequent Scientific Valuation
The stock valuation mechanism determines Sequent Scientific's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Sequent Scientific based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sequent Scientific. We calculate exposure to Sequent Scientific's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sequent Scientific's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 5.6 B | 3.3 B |
Additional Tools for Sequent Stock Analysis
When running Sequent Scientific's price analysis, check to measure Sequent Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sequent Scientific is operating at the current time. Most of Sequent Scientific's value examination focuses on studying past and present price action to predict the probability of Sequent Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sequent Scientific's price. Additionally, you may evaluate how the addition of Sequent Scientific to your portfolios can decrease your overall portfolio volatility.